both | Male | Female | 1990–2019 EAPC No. (95% CI) | ||||
---|---|---|---|---|---|---|---|
Case | Rate per 100,000 | Case | Rate per 100,000 | Case | Rate per 100,000 | ||
Total cancer | 3,487,482 | 1260.90 | 1,923,318 | 1667.95 | 1,564,164 | 969.86 | -0.05 (0.07 ~ -0.16) |
Lung cancer | 701,015 | 253.45 | 445,168 | 386.06 | 255,847 | 158.64 | 0.68 (0.95 ~ 0.42) |
Colon and rectum cancer | 468,185 | 169.27 | 226,604 | 196.52 | 241,581 | 149.79 | 0.01 (0.33 ~ -0.31) |
Stomach cancer | 346,650 | 125.33 | 199,465 | 172.98 | 147,185 | 91.26 | -1.1 (-0.82 ~ -1.48) |
Prostate cancer | 308,160 | 111.41 | 308,160 | 267.24 | – | – | -0.32 (0.07 ~ -0.70) |
Pancreatic cancer | 205,547 | 74.32 | 89,873 | 77.94 | 115,675 | 71.72 | 0.10 (1.52 ~ 0.48) |
Breast cancer | 182,595 | 66.02 | 3410 | 2.96 | 179,186 | 111.10 | -0.48 (0.01 ~ -0.97) |
Esophageal cancer | 156,277 | 56.50 | 101,739 | 88.23 | 54,538 | 33.82 | -0.45 (0.07 ~ -0.97) |
Liver cancer | 139,039 | 50.27 | 80,105 | 69.47 | 58,935 | 36.54 | -0.54 (0.031 ~ -1.10) |
Bladder cancer | 125,997 | 45.55 | 89,449 | 77.57 | 36,548 | 22.66 | -0.27 (0.34 ~ -0.87) |
Leukemia | 98,229 | 35.51 | 52,845 | 45.83 | 45,384 | 28.14 | -0.05 (0.63 ~ -0.74) |
Non-Hodgkin lymphoma | 88,570 | 32.02 | 44,157 | 38.29 | 44,413 | 27.54 | 0.31 (1.06 ~ -0.43) |
Gallbladder and biliary | 74,599 | 26.97 | 29,795 | 25.84 | 44,804 | 27.78 | -0.36 (0.42 ~ -1.13) |
Kidney cancer | 61,620 | 22.28 | 36,019 | 31.24 | 25,601 | 15.87 | 1.05 (1.98 ~ 0.12) |
Ovarian cancer | 52,315 | 18.91 | – | – | 52,315 | 32.44 | -0.31 (0.61 ~ -1.23) |
Lip and oral cavity cancer | 49,820 | 18.01 | 26,858 | 23.29 | 22,962 | 14.24 | 0.37 (1.39 ~ -0.64) |
Cervical cancer | 48,158 | 17.41 | – | – | 48,158 | 29.86 | -0.91 (0.02 ~ -1.82) |
Multiple myeloma | 45,876 | 16.59 | 22,733 | 19.71 | 23,144 | 14.35 | 0.23 (1.26 ~ -0.79) |
Brain and central nervous | 44,701 | 16.16 | 21,684 | 18.81 | 23,017 | 14.27 | 1.09 (2.18 ~ 0.00) |
Non-melanoma skin cancer | 30,240 | 10.93 | 16,243 | 14.09 | 13,997 | 8.68 | 0.92 (2.27 ~ -0.41) |
Uterine cancer | 29,990 | 10.84 | – | – | 29,990 | 18.60 | -0.75 (0.42 ~ -1.91) |
Larynx cancer | 28,527 | 10.31 | 23,509 | 20.39 | 5018 | 3.11 | -0.74 (0.49 ~ -1.96) |
Malignant skin melanoma | 22,378 | 8.09 | 11,604 | 10.06 | 10,774 | 6.68 | 0.46 (1.95 ~ -1.01) |
Other pharynx cancer | 20,239 | 7.32 | 14,369 | 12.46 | 5870 | 3.64 | 1.02 (2.71 ~ -0.64) |
Thyroid cancer | 16,561 | 5.99 | 6329 | 5.49 | 10,232 | 6.34 | 0.22 (1.94 ~ -1.47) |
Mesothelioma | 11,680 | 4.22 | 8791 | 7.62 | 2889 | 1.79 | 0.41 (2.48 ~ -1.62) |
Nasopharynx cancer | 10,145 | 3.67 | 6442 | 5.59 | 3703 | 2.30 | -0.88 (1.19 ~ -2.91) |
Hodgkin lymphoma | 4364 | 1.58 | 2288 | 1.98 | 2076 | 1.29 | -1.95 (0.96 ~ -4.78) |
Testicular cancer | 1254 | 0.45 | 1254 | 1.09 | – | – | 0.07 (6.70 ~ -6.14) |
Other malignant neoplasms | 114,750 | 41.49 | 54,423 | 47.20 | 60,326 | 37.41 | 0.13 (0.78 ~ -0.51) |